Science Translational Medicine: ‘Creating Hope Act’ incentivizes pediatric drug R&D
Washington, DC — Recent legislative and regulatory actions make great strides toward establishing much needed incentives for pharmaceutical companies and others to develop and test more medications for pediatric rare diseases, including pediatric…